Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Apr 08, 2019 2:00pm
99 Views
Post# 29597721

RE:RE:RE:RE:TLTFF

RE:RE:RE:RE:TLTFF
robertshaw wrote:
Bunge wrote: And away it all went.

I knew I shouldn't have said anything.



 


Basementboy blowjobjoe's boss probably still thinks they could start a short attack like a month ago from 49 cents to 40 cents within 10 minutes, now after the American media exposure this story, not gonna happen now. With more and more people aware of this is a good bargain around mid 50, not possible for low ball offer like last week 's even high 40 can get filled. And we are heading higher and higher with more people join in now...


What American media exposure? The media outlet of a little town of 48,000 in Virginia? You need to see the CEO being interviewed on BNN or the Midas Letter. Exposure on Seeking Alpha would be a big help but I don't know if they get into Venture stocks. The perfect solution would be a pharma joint venture even if TLT has to issue millions of more shares to participate. It would be a sign that somebody in the medical community believes in the treatment and is willing to financially help quicken the efficacy process. IMO, if a JV doesn't happen and TLT is forced to go it alone through a PP there will be a lot of disappointed new investors.

Bullboard Posts